Corcept Therapeutics
CORT
#2966
Rank
S$5.75 B
Marketcap
$53.30
Share price
-3.19%
Change (1 day)
18.87%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.15 B

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are S$0.15 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.15 B38.63%
2022-12-31S$0.10 B69.14%
2021-12-31S$64.66 M1.08%
2020-12-31S$63.97 M15.68%
2019-12-31S$55.3 M13.37%
2018-12-31S$48.78 M23.35%
2017-12-31S$39.54 M-0.18%
2016-12-31S$39.61 M-16.23%
2015-12-31S$47.29 M-5.85%
2014-12-31S$50.23 M-5.75%
2013-12-31S$53.29 M16.49%
2012-12-31S$45.75 M602.93%
2011-12-31S$6.5 M30.85%
2010-12-31S$4.97 M46.33%
2009-12-31S$3.39 M-17.57%
2008-12-31S$4.12 M-5.24%
2007-12-31S$4.35 M-19.87%
2006-12-31S$5.43 M-8.45%
2005-12-31S$5.93 M120.57%
2004-12-31S$2.68 M-96.35%
2003-12-31S$73.61 M-2.99%
2002-12-31S$75.88 M2075.86%
2001-12-31S$3.48 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$142.69 B 92,494.16%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.04 B 65,469.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$72.42 B 46,896.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$75.85 B 49,125.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$167.00 B 108,272.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$89.85 B 58,205.16%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.90 B 488.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.87 B 465.97%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.31 B 1,405.19%๐Ÿ‡บ๐Ÿ‡ธ USA